These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36579127)

  • 1. Treatment of Carbapenem-Resistant Multidrug-Resistant Gram-Negative Bacilli with Intracerebroventricular Injection of Polymyxin B: A Retrospective Study.
    Liu D; Niu J; Chen G; Xu L
    Infect Drug Resist; 2022; 15():7653-7666. PubMed ID: 36579127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Clinical Study on the Use of Intraventricular Polymyxin B Supplemented by Continuous External Ventricular Drainage in the Treatment of Drug-Resistant Gram-Negative Bacilli Intracranial Infection.
    Chen H; Guo X; Xie D; Dong X; Niu J; Chen G
    Infect Drug Resist; 2020; 13():2963-2970. PubMed ID: 32904679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of Using Intraventricular Plus Intravenous Polymyxin B in Post-neurosurgical Patients With Multi/Extensively Drug-Resistant Gram-Negative Bacteria-Induced Intracranial Infection.
    Li H; Yu W; Wang G; Cai H
    Front Med (Lausanne); 2022; 9():913364. PubMed ID: 35872774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraventricular or intrathecal polymyxin B for treatment of post-neurosurgical intracranial infection caused by carbapenem-resistant gram-negative bacteria: a 8-year retrospective study.
    Hu Y; Li D; Zhang G; Dai Y; Chen M; Jiang H; Cui W
    Eur J Clin Microbiol Infect Dis; 2024 May; 43(5):875-884. PubMed ID: 38443737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of combination therapy with intrathecal or intraventricular administration of polymyxin B for hospital-acquired central nervous system infections caused by carbapenem-resistant Acinetobacter baumannii: a retrospective study.
    Xu C; Zeng F; Xu Q; Yang Y; Zhang Y; Shi C
    Int J Antimicrob Agents; 2024 Sep; ():107334. PubMed ID: 39312980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of intravenous plus intrathecal/intracerebral ventricle injection of polymyxin B for post-neurosurgical intracranial infections due to MDR/XDR
    Pan S; Huang X; Wang Y; Li L; Zhao C; Yao Z; Cui W; Zhang G
    Antimicrob Resist Infect Control; 2018; 7():8. PubMed ID: 29387342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical study on intravenous combined with aerosol inhalation of polymyxin B for the treatment of pneumonia caused by multidrug-resistant Gram-negative bacteria].
    Zhou L; Li C; Weng Q; Wu J; Luo H; Xue Z; Xiao Y; Chen C
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Apr; 33(4):416-420. PubMed ID: 34053483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraventricular Plus Systemic Antibiotic Therapy for Treating Polymyxin-Resistant
    Wang H; Zhou Q; Huang K; Yang X; Wen L
    Open Forum Infect Dis; 2022 Apr; 9(4):ofac084. PubMed ID: 35355891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of intraventricular polymyxin B plus continuous ventricular drainage for the treatment of intracranial infection caused by drug-resistant Acinetobacter baumannii.
    Chen L; Li X; Li D; Dong X; Chen H
    Ann Palliat Med; 2022 Feb; 11(2):490-497. PubMed ID: 35249326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic drug monitoring of polymyxin B cerebrospinal fluid concentrations in patients with carbapenem-resistant Gram-negative bacteria-induced central nervous system infection.
    Wang P; Liu S; He X; Miao W; Sun T; Yang J
    J Antimicrob Chemother; 2024 Aug; 79(8):1969-1973. PubMed ID: 38870067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical use of intravenous polymyxin B for the treatment of patients with multidrug-resistant Gram-negative bacterial infections: An evaluation of the current evidence.
    Falagas ME; Kyriakidou M; Voulgaris GL; Vokos F; Politi S; Kechagias KS
    J Glob Antimicrob Resist; 2021 Mar; 24():342-359. PubMed ID: 33486122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful Treatment With Intrathecal and Intravenous Polymyxin B-Based Combination Against MDR
    Xing H; Cheng C; Zhang Y; Cai Y; Wang X; Deng D; Xu L; Xu M; Chen J
    Front Pediatr; 2021; 9():564991. PubMed ID: 34386463
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical Characteristics of Hydrocephalus Following the Treatment of Pyogenic Ventriculitis Caused by Multi/Extensive Drug-Resistant Gram-Negative
    Pandey S; Yao PW; Qian Z; Ji T; Wang K; Gao L
    Front Surg; 2022; 9():854627. PubMed ID: 35592123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical analysis of sepsis with extensively drug resistant Gram-negative bacteria in intensive care unit treated with polymyxin B-based combination therapy].
    Zhao S; Yan L; Wang C; Peng M
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Feb; 32(2):150-154. PubMed ID: 32274997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose intravenous plus inhaled versus intravenous polymyxin B for the treatment of extensive drug-resistant Gram-negative ventilator-associated pneumonia in the critical illnesses: a multi-center matched case-control study.
    Liu J; Shao M; Xu Q; Liu F; Pan X; Wu J; Xiong L; Wu Y; Tian M; Yao J; Huang S; Zhang L; Chen Y; Zhang S; Wen Z; Du H; TaoWang ; Liu Y; Li W; Xu Y; Teboul JL; Chen D
    Ann Intensive Care; 2022 Aug; 12(1):72. PubMed ID: 35934730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
    Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
    Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymyxin Monotherapy vs. Combination Therapy for the Treatment of Multidrug-resistant Infections: A Systematic Review and Meta-analysis.
    Samal S; Samir SB; Patra SK; Rath A; Dash A; Nayak B; Mohanty D
    Indian J Crit Care Med; 2021 Feb; 25(2):199-206. PubMed ID: 33707900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-drug resistant gram negative infections and use of intravenous polymyxin B in critically ill children of developing country: retrospective cohort study.
    Siddiqui NU; Qamar FN; Jurair H; Haque A
    BMC Infect Dis; 2014 Nov; 14():626. PubMed ID: 25430979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftazidime-Avibactam for the Treatment of Central Nervous System Infection Caused by Pan Drug-Resistant Carbapenem-Resistant Klebsiella Pneumoniae: A Case Report.
    Zhang Y; Hou G; Zhang L; Li S
    Infect Drug Resist; 2024; 17():3501-3506. PubMed ID: 39157745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential intraventricular injection of tigecycline and polymyxin B in the treatment of intracranial Acinetobacter baumannii infection after trauma: a case report and review of the literature.
    Zhong L; Shi XZ; Su L; Liu ZF
    Mil Med Res; 2020 May; 7(1):23. PubMed ID: 32389124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.